Aspen Aerogels, Inc. (NYSE:ASPN) Short Interest Update

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 7,017,875 shares, a growth of 12.6% from the March 31st total of 6,232,371 shares. Based on an average daily trading volume, of 1,335,401 shares, the short-interest ratio is presently 5.3 days. Approximately 8.7% of the shares of the company are short sold.

Institutional Trading of Aspen Aerogels

A number of institutional investors have recently added to or reduced their stakes in ASPN. Royal Bank of Canada lifted its holdings in Aspen Aerogels by 84.7% during the 1st quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock worth $360,000 after purchasing an additional 25,880 shares in the last quarter. AQR Capital Management LLC purchased a new stake in Aspen Aerogels during the 1st quarter worth about $960,000. Integrated Wealth Concepts LLC purchased a new stake in Aspen Aerogels during the 1st quarter worth about $84,000. Goldman Sachs Group Inc. lifted its holdings in Aspen Aerogels by 89.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after purchasing an additional 602,586 shares in the last quarter. Finally, Caxton Associates LLP purchased a new stake in Aspen Aerogels during the 1st quarter worth about $307,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $4.26 on Friday. The stock’s 50-day simple moving average is $3.41 and its 200 day simple moving average is $3.90. The stock has a market capitalization of $352.44 million, a price-to-earnings ratio of -0.90 and a beta of 2.83. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.29 and a current ratio of 3.90. Aspen Aerogels has a 52-week low of $2.30 and a 52-week high of $9.78.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.07). The company had revenue of $41.34 million for the quarter, compared to analysts’ expectations of $44.25 million. Aspen Aerogels had a negative return on equity of 13.91% and a negative net margin of 143.69%.The business’s revenue for the quarter was down 66.4% on a year-over-year basis. During the same period last year, the company posted $0.14 EPS. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. Research analysts forecast that Aspen Aerogels will post -0.76 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently commented on ASPN shares. TD Cowen dropped their price target on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 15th. Roth Mkm dropped their price target on Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Barclays dropped their price target on Aspen Aerogels from $4.00 to $3.00 and set an “underweight” rating on the stock in a research report on Thursday, March 5th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Friday, March 27th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $4.25.

Read Our Latest Stock Report on Aspen Aerogels

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

See Also

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.